Publication:
Effectiveness of bendamustine in relapse or refractory lymphoma cases: a report from Turkey-The Turkish Oncology Group (TOG) study.

dc.conference.dateJUN 02-07, 2017
dc.conference.locationChicago, Illinois
dc.conference.organizer53rd Annual Clinical Meeting of the American-Society-of-Clinical-Oncology (ASCO)
dc.contributor.coauthorKaradurmuş, Nuri
dc.contributor.coauthorPaydaş, Semra
dc.contributor.coauthorÖcal, Ramazan
dc.contributor.coauthorYıldız, Birol
dc.contributor.coauthorNayır, Erdinç
dc.contributor.coauthorDoğan, Mutlu
dc.contributor.coauthorSümbül, Ahmet Taner
dc.contributor.coauthorSürmeli, Zeki
dc.contributor.coauthorBarista, İbrahim
dc.contributor.coauthorÖzgür, Gökhan
dc.contributor.coauthorErtürk, İsmail
dc.contributor.coauthorÖzaydın, Şükrü
dc.contributor.coauthorPetekkaya, Halil İbrahim
dc.contributor.coauthorUskent, Necdet
dc.contributor.departmentSchool of Medicine
dc.contributor.facultymemberYes
dc.contributor.kuauthorFerhanoğlu, Ahmet Burhan
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-11-09T23:19:24Z
dc.date.issued2017
dc.description.fulltextNo
dc.description.harvestedfromManual
dc.description.indexedbyWOS
dc.description.openaccessNO
dc.description.peerreviewstatusN/A
dc.description.publisherscopeInternational
dc.description.readpublishN/A
dc.description.sponsoredbyTubitakEuN/A
dc.description.versionN/A
dc.identifier.doi10.1200/JCO.2017.35.15_suppl.e19027
dc.identifier.eissn1527-7755
dc.identifier.embargoN/A
dc.identifier.issn0732-183X
dc.identifier.quartileQ1
dc.identifier.urihttps://doi.org/10.1200/JCO.2017.35.15_suppl.e19027
dc.identifier.urihttps://hdl.handle.net/20.500.14288/10545
dc.identifier.volume35
dc.identifier.wos000411932200057
dc.keywordsBendamustine
dc.keywordsHodgkin's lymphoma
dc.keywordsNon-hodgkin's lymphoma
dc.keywordsChronic lymphocytic leukemia
dc.keywordsRelapsed lymphoma
dc.keywordsRefractory lymphoma
dc.language.isoeng
dc.publisherLippincott Williams and Wilkins
dc.relation.affiliationKoç University
dc.relation.collectionKoç University Institutional Repository
dc.relation.ispartofJournal of Clinical Oncology
dc.relation.openaccessN/A
dc.rightsN/A
dc.subjectOncology
dc.titleEffectiveness of bendamustine in relapse or refractory lymphoma cases: a report from Turkey-The Turkish Oncology Group (TOG) study.
dc.typeMeeting Abstract
dspace.entity.typePublication
local.contributor.kuauthorFerhanoğlu, Ahmet Burhan
relation.isGoalOfPublicationa9786601-9431-4553-9a46-013bb366fb87
relation.isGoalOfPublication.latestForDiscoverya9786601-9431-4553-9a46-013bb366fb87
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files